Dolby Laboratories Ownership

DLB Stock  USD 78.32  0.12  0.15%   
Dolby Laboratories holds a total of 59.77 Million outstanding shares. The majority of Dolby Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Dolby Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Dolby Laboratories. Please pay attention to any change in the institutional holdings of Dolby Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2002-12-31
Previous Quarter
97 M
Current Value
96.6 M
Avarage Shares Outstanding
104.6 M
Quarterly Volatility
7.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Dolby Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Dolby Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Payout Ratio is expected to grow to 0.54, whereas Dividends Paid is projected to grow to (108.9 M). The current year's Common Stock Shares Outstanding is expected to grow to about 113.5 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 201.3 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.

Dolby Stock Ownership Analysis

About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Dolby Laboratories was currently reported as 25.45. The company has Price/Earnings To Growth (PEG) ratio of 2.08. Dolby Laboratories last dividend was issued on the 19th of August 2024. Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California. Dolby Laboratories operates under Information Technology Services classification in the United States and is traded on New York Stock Exchange. It employs 2368 people. To learn more about Dolby Laboratories call Kevin Yeaman at 415 558 0200 or check out https://www.dolby.com.
Besides selling stocks to institutional investors, Dolby Laboratories also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Dolby Laboratories' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Dolby Laboratories' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Dolby Laboratories Quarterly Liabilities And Stockholders Equity

3.11 Billion

Dolby Laboratories Insider Trades History

Only 1.47% of Dolby Laboratories are currently held by insiders. Unlike Dolby Laboratories' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Dolby Laboratories' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Dolby Laboratories' insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Dolby Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Dolby Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dolby Laboratories backward and forwards among themselves. Dolby Laboratories' institutional investor refers to the entity that pools money to purchase Dolby Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Mackenzie Investments2024-09-30
985.8 K
Wells Fargo & Co2024-06-30
977.6 K
Dimensional Fund Advisors, Inc.2024-09-30
870.5 K
Schroder Investment Management Group2024-06-30
763.1 K
Charles Schwab Investment Management Inc2024-09-30
717.6 K
First Trust Advisors L.p.2024-06-30
697.6 K
Norges Bank2024-06-30
633.9 K
Aqr Capital Management Llc2024-06-30
627.2 K
Jpmorgan Chase & Co2024-06-30
616.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
11.7 M
Vanguard Group Inc2024-09-30
M
Note, although Dolby Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Dolby Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dolby Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dolby Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dolby Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Avadis Tevanian a day ago
Acquisition by Avadis Tevanian of 2952 shares of Dolby Laboratories subject to Rule 16b-3
 
Ryan Nicholson few days ago
Disposition of 10500 shares by Ryan Nicholson of Dolby Laboratories at 31.73 subject to Rule 16b-3
 
John Couling few days ago
Disposition of 7000 shares by John Couling of Dolby Laboratories at 64.6 subject to Rule 16b-3
 
Dolby Dagmar over a week ago
Disposition of 500000 shares by Dolby Dagmar of Dolby Laboratories subject to Rule 16b-3
 
Kevin Yeaman over a month ago
Acquisition by Kevin Yeaman of 246 shares of Dolby Laboratories at 42.98 subject to Rule 16b-3
 
Kevin Yeaman over a month ago
Disposition of 9816 shares by Kevin Yeaman of Dolby Laboratories at 74.5467 subject to Rule 16b-3
 
John Couling over a month ago
Disposition of 21120 shares by John Couling of Dolby Laboratories at 62.32 subject to Rule 16b-3
 
Mark Sherman over two months ago
Acquisition by Mark Sherman of 5738 shares of Dolby Laboratories subject to Rule 16b-3
 
Todd Pendleton over three months ago
Disposition of 5118 shares by Todd Pendleton of Dolby Laboratories subject to Rule 16b-3
 
Kevin Yeaman over three months ago
Acquisition by Kevin Yeaman of tradable shares of Dolby Laboratories at 78.15 subject to Rule 16b-3
 
Revankar Shriram over six months ago
Disposition of 4409 shares by Revankar Shriram of Dolby Laboratories at 83.7 subject to Rule 16b-3
 
Kevin Yeaman over six months ago
Bona fide gift to Kevin Yeaman of 81884 shares of Dolby Laboratories subject to Section 16

Dolby Laboratories Outstanding Bonds

Dolby Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dolby Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dolby bonds can be classified according to their maturity, which is the date when Dolby Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Dolby Laboratories Corporate Filings

F4
27th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
19th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
13th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
1st of November 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.353
Earnings Share
2.69
Revenue Per Share
13.172
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0516
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.